Search hospitals
>
Quebec
>
MONTREAL
Jewish General Hospital
Claim this profile
MONTREAL, Quebec H3T 1E2
Global Leader in Breast Cancer
Global Leader in Cancer
Conducts research for Lung Cancer
Conducts research for Prostate Cancer
Conducts research for Colorectal Cancer
527 reported clinical trials
31 medical researchers
Summary
Jewish General Hospital is a medical facility located in MONTREAL, Quebec. This center is recognized for care of Breast Cancer, Cancer, Lung Cancer, Prostate Cancer, Colorectal Cancer and other specialties. Jewish General Hospital is involved with conducting 527 clinical trials across 578 conditions. There are 31 research doctors associated with this hospital, such as Cristiano Ferrario, MD, Dr. Tamim Niazi, MDCM, Petr Kavan, Dr, and Wilson Miller.
Area of expertise
Breast Cancer
Jewish General Hospital has run 105 trials for Breast Cancer. Some of their research focus areas include:
Cancer
Jewish General Hospital has run 51 trials for Cancer. Some of their research focus areas include:
Top PIs
Cristiano Ferrario, MD
Jewish General Hospital
9 years of reported clinical research
Dr. Tamim Niazi, MDCM
Jewish General Hospital, McGill University
5 years of reported clinical research
Petr Kavan, Dr
Jewish General Hospital
3 years of reported clinical research
Wilson Miller
Jewish General Hospital
3 years of reported clinical research
Clinical Trials running at Jewish General Hospital
Breast Cancer
Multiple Myeloma
Lung Cancer
Prostate Cancer
Chronic Lymphocytic Leukemia
Lymphoma
Cancer
Follicular Lymphoma
Mantle Cell Lymphoma
Brain Tumor
sac-TMT + Pembrolizumab
for Breast Cancer
This is a randomized, open-label study comparing the efficacy and safety of adjuvant sacituzumab tirumotecan (MK-2870) in combination with pembrolizumab compared to treatment of physician's choice (TPC) in participants with triple-negative breast cancer (TNBC) who received neoadjuvant therapy and did not achieve a pathological complete response (pCR) at surgery. The primary objective is to compare sacituzumab tirumotecan plus pembrolizumab to TPC (pembrolizumab or pembrolizumab plus capecitabine) with respect to invasive disease-free survival (iDFS) per investigator assessment. It is hypothesized that sacituzumab tirumotecan plus pembrolizumab is superior to TPC with respect to iDFS per investigator assessment.
Recruiting
2 awards
Phase 3
5 criteria
Sacituzumab Tirumotecan + Pembrolizumab
for Breast Cancer
Researchers want to know if sacituzumab tirumotecan given alone or with pembrolizumab can treat triple negative breast cancer (TNBC). The main goal of this study is to learn if people treated with sacituzumab tirumotecan alone or with pembrolizumab live longer overall or without the cancer growing or spreading compared to people treated with chemotherapy.
Recruiting
2 awards
Phase 3
3 criteria
Chemotherapy + Hormone Therapy
for Breast Cancer
This trial is testing if adding additional cancer-fighting drugs to treatments that stop certain body functions is better than just using the treatments that stop those functions alone. It targets younger women with early-stage breast cancer who have a higher risk of dying from the disease. The treatment works by stopping certain body functions and using drugs to kill cancer cells.
Recruiting
2 awards
Phase 3
19 criteria
Similar Hospitals nearby
Select from list below to view details
Frequently asked questions
What kind of research happens at Jewish General Hospital?
Jewish General Hospital is a medical facility located in MONTREAL, Quebec. This center is recognized for care of Breast Cancer, Cancer, Lung Cancer, Prostate Cancer, Colorectal Cancer and other specialties. Jewish General Hospital is involved with conducting 527 clinical trials across 578 conditions. There are 31 research doctors associated with this hospital, such as Cristiano Ferrario, MD, Dr. Tamim Niazi, MDCM, Petr Kavan, Dr, and Wilson Miller.
Where is Jewish General Hospital located?
**Directions to Jewish General Hospital, Montreal:** - **By Car:** Take I-5 North to Exit 66, then follow the signs for the hospital on Ch de la Côte-Ste-Catherine. - **By Public Transportation:** Take the LIGNE 2 - ORANGE metro line to Station Plamondon. The hospital is a 13-minute walk from the station.
Who should I call to ask about financial aid or insurance network?
For financial assistance at Jewish General Hospital, contact the Financial Assistance department at 514-340-8222, extension 22230, for details on qualification and application. For insurance inquiries, use the hospital's main line at 514-340-8222. Questions regarding fees for medical services should be directed to the Patient Account Office, available at the same contact number.
What insurance does Jewish General Hospital accept?
The Jewish General Hospital, located in Montreal, Quebec, Canada, is a key institution within the Integrated Health and Social Services University Network for West-Central Montreal (CIUSSS West-Central Montreal). Residents of Quebec with private insurance are required to present proof of insurance coverage during hospitalization. For specific insurance plan acceptance and coverage verification, it is advised to directly contact the hospital or your insurance provider.
What awards or recognition has Jewish General Hospital received?
The Jewish General Hospital, located in Montreal, Quebec, is renowned for its pioneering research in cancer treatment at the Segal Cancer Centre. It houses the Lady Davis Institute, one of Canada's leading biomedical research institutions, with expertise in cancer, aging, epidemiology, AIDS, cardiovascular disease, genetics, and more. This hospital is acknowledged globally for its contributions to various fields, including emergency medicine, nephrology, and the psychosocial aspects of illness.
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.